Phase 3 Parkinson's Disease Trial, Not Yet Recruiting NCT07395531 Sponsor: Dr. Ram Manohar Lohia Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 3 Parkinson's Disease Trial, Not Yet Recruiting

NCT07395531
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease according to a specific set of internationally recognised diagnostic guidelines (the Movement Disorder Society criteria).
  • People whose Parkinson's disease falls within a certain range of severity, from moderate to moderately severe, as measured by a standard rating scale called Hoehn & Yahr stages 2–4.
  • People who have been on a stable, unchanged medication routine for at least one month before entering the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have other neurological or psychiatric conditions that could affect the study results.
  • People who have metal objects or electrical stimulators located in the head.
  • People who have previously had deep brain stimulation surgery.
  • People who have a history of seizures or epilepsy.
  • People who have a skull defect resulting from a prior surgery, such as removal of part of the skull (craniectomy).
  • People who have a scalp condition that would likely interfere with the placement of electrodes on the head.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026

Contact this trial

Principal Investigator: Ashish Kumar Duggal, DM (Neurology), Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi

Phone: +919810523332

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Dr. Ram Manohar Lohia Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
30 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇳 India

Primary endpoints

To determine change in motor function score as assessed by Movement Disorder Society - Unified Parkinson's Disease Rating Scale Part - III scale 1 week after the repetitive tDCS (Minimum Score 0, Maximum Score 132, higher scores indicate more disability)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov